Looking To Position Yourself as a Leader Within the CNS Space?
With the success of Lecanemab and Donanemab motivating more companies than ever to follow suit, and big pharma investments, such as Abbvie’s $8.7 billion acquisition of Cerevel, emphasizing neuroscience prioritization, momentum in Alzheimer’s and Parkinson’s research is at an all-time high.
This March, connect with an exclusive group of 150+ senior decision makers at the 13th Alzheimer’s & Parkinson’s Drug Development Summit, from large pharma heavyweights to well-established and new, innovative biotechs. In a field where biopharma trusts their long-established partners, seize the opportunity to stand out in a competitive market and showcase your distinctive value proposition.
There are a limited number of partnerships available, including speaking positions across the full agenda, reserved exclusively for high-quality companies. If you provide services in assay development, neuroimaging, drug discovery, in vitro or in vivo modelling, or clinical research that would benefit this niche audience of CNS decision-makers, now is the time to secure new business and form lasting connections with the companies seeking solutions to progress their Alzheimer’s and Parkinson’s drug products to market.
Alzheimer’s & Parkinson’s Drug Developers Need Your Help With:
Fluid/Assay Biomarkers
Neuroimaging
Digital Biomarkers
In Vivo Models
In Vitro Models
Clinical & Preclinical CROs
Biomarker Discovery Platforms
2025 Partners
Why Partner?
Build connections with your target audience you’ve been looking to meet from senior CNS decision makers from large pharma increasing their spend in neuroscience R&D, to well established and new biotechs expanding their neurodegeneration pipelines
Gain brand visibility: broaden your company’s exposure to our intimate audience of 150+ senior biopharma leaders you won’t see at ADPD or CTAD
Educate the industry: speak on the main agenda to leverage your expertise alongside senior KOLs from biopharma to gain credibility and build trust, distinguishing your unique value proposition from your competitors
Secure new business with exclusive market insights selectively curated by the Hanson Wade team to get into the crux of your customers’ pain points and differentiate your brand as what your customers are looking for
Cement your company as the leading provider for your service in neurodegenerative research and development
